Rgfp966
RGFP966 is a selective and potent histone deacetylase (HDAC) inhibitor developed by Merck Group. It exhibits inhibitory activity against HDAC class I enzymes, particularly HDAC3. The compound is commonly used in scientific research applications to study the biological functions of HDAC enzymes.
Lab products found in correlation
6 protocols using rgfp966
NSCLC Cell Line Cultivation and HDAC Inhibitor Treatments
Isolation and Culture of Murine Chondrocytes
HDAC Inhibition Regulates Xist Induction
Ovalbumin-Induced Inflammation: Adjuvants and Inhibitors
Histone Deacetylase Inhibitor Evaluation
Inducible XIST Expression in HT1080 Cell Line
Sigma-Aldrich). Inhibition of the catalytic activity of KMT5A (also known as PR-SET7/SET8/SETD8) was performed using the chemical ryuvidine from Abcam. Inhibition of PRC2 and PRC1 was performed using GSK343 and PRT4165 (both from Sigma-Aldrich) as described previously (13) .
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!